Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial Infarction.

Nishikido T, Oyama J, Shiraki A, Komoda H, Node K.

J Am Heart Assoc. 2016 Apr 4;5(4):e002863. doi: 10.1161/JAHA.115.002863.

2.

The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury.

Zhang P, Weaver JC, Chen G, Beretov J, Atsumi T, Qi M, Bhindi R, Qi JC, Madigan MC, Giannakopoulos B, Krilis SA.

PLoS One. 2016 Mar 31;11(3):e0152681. doi: 10.1371/journal.pone.0152681. eCollection 2016.

3.

Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury.

Lin D, Ma J, Xue Y, Wang Z.

PLoS One. 2015 Dec 2;10(12):e0138051. doi: 10.1371/journal.pone.0138051. eCollection 2015.

4.

C5a inhibitor protects against ischemia/reperfusion injury in rat small intestine.

Tuboly E, Futakuchi M, Varga G, Érces D, Tőkés T, Mészáros A, Kaszaki J, Suzui M, Imai M, Okada A, Okada N, Boros M, Okada H.

Microbiol Immunol. 2016 Jan;60(1):35-46. doi: 10.1111/1348-0421.12338.

5.

Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Khan MA, Hsu JL, Assiri AM, Broering DC.

Clin Exp Immunol. 2016 Feb;183(2):175-86. doi: 10.1111/cei.12713. Epub 2015 Nov 5. Review.

PMID:
26404106
6.

Regulation of signal transduction by reactive oxygen species in the cardiovascular system.

Brown DI, Griendling KK.

Circ Res. 2015 Jan 30;116(3):531-49. doi: 10.1161/CIRCRESAHA.116.303584. Review.

7.

Human mannose-binding lectin inhibitor prevents myocardial injury and arterial thrombogenesis in a novel animal model.

Pavlov VI, Tan YS, McClure EE, La Bonte LR, Zou C, Gorsuch WB, Stahl GL.

Am J Pathol. 2015 Feb;185(2):347-55. doi: 10.1016/j.ajpath.2014.10.015. Epub 2014 Dec 4.

8.

Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.

Soukoulis V, Boden WE, Smith SC Jr, O'Gara PT.

Circ Res. 2014 Jun 6;114(12):1944-58. doi: 10.1161/CIRCRESAHA.114.302804. Review.

9.

Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction.

Wysoczynski M, Solanki M, Borkowska S, van Hoose P, Brittian KR, Prabhu SD, Ratajczak MZ, Rokosh G.

Stem Cells. 2014 Sep;32(9):2502-15. doi: 10.1002/stem.1743.

10.

Association between endogenous complement inhibitor and myocardial salvage in patients with myocardial infarction.

Holt CB, Thiel S, Munk K, Østergaard JA, Bøtker HE, Hansen TK.

Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):3-9. doi: 10.1177/2048872613507004. Epub 2013 Sep 30.

11.

Protective Effects of Shen-Yuan-Dan, a Traditional Chinese Medicine, against Myocardial Ischemia/Reperfusion Injury In Vivo and In Vitro.

Liu H, Shang J, Chu F, Li A, Wu B, Xie X, Liu W, Yang H, Tong T.

Evid Based Complement Alternat Med. 2013;2013:956397. doi: 10.1155/2013/956397. Epub 2013 Dec 23.

12.

Serum extracellular vesicle protein levels are associated with acute coronary syndrome.

de Hoog VC, Timmers L, Schoneveld AH, Wang JW, van de Weg SM, Sze SK, van Keulen JK, Hoes AW, den Ruijter HM, de Kleijn DP, Mosterd A.

Eur Heart J Acute Cardiovasc Care. 2013 Mar;2(1):53-60. doi: 10.1177/2048872612471212. Erratum in: Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):292.

13.

Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis.

Mastellos DC, Deangelis RA, Lambris JD.

Semin Immunol. 2013 Feb;25(1):29-38. doi: 10.1016/j.smim.2013.04.002. Epub 2013 May 17. Review.

14.

Complement anaphylatoxins C3a and C5a induce a failing regenerative program in cardiac resident cells. Evidence of a role for cardiac resident stem cells other than cardiomyocyte renewal.

Lara-Astiaso D, Izarra A, Estrada JC, Albo C, Moscoso I, Samper E, Moncayo J, Solano A, Bernad A, Díez-Juan A.

Springerplus. 2012 Dec;1(1):63. doi: 10.1186/2193-1801-1-63. Epub 2012 Dec 12.

15.

Pexelizumab and survival in cardiac surgery.

Testa L, Meco M, Cirri S, Bedogni F.

HSR Proc Intensive Care Cardiovasc Anesth. 2011;3(1):23-4.

16.

Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

Hausenloy DJ, Yellon DM.

J Clin Invest. 2013 Jan;123(1):92-100. doi: 10.1172/JCI62874. Epub 2013 Jan 2. Review.

17.

Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis.

Pavlov VI, Skjoedt MO, Siow Tan Y, Rosbjerg A, Garred P, Stahl GL.

Circulation. 2012 Oct 30;126(18):2227-35. doi: 10.1161/CIRCULATIONAHA.112.123968. Epub 2012 Oct 2.

18.

The complement system in ischemia-reperfusion injuries.

Gorsuch WB, Chrysanthou E, Schwaeble WJ, Stahl GL.

Immunobiology. 2012 Nov;217(11):1026-33. doi: 10.1016/j.imbio.2012.07.024. Epub 2012 Aug 7. Review.

19.

Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.

Orsini F, Villa P, Parrella S, Zangari R, Zanier ER, Gesuete R, Stravalaci M, Fumagalli S, Ottria R, Reina JJ, Paladini A, Micotti E, Ribeiro-Viana R, Rojo J, Pavlov VI, Stahl GL, Bernardi A, Gobbi M, De Simoni MG.

Circulation. 2012 Sep 18;126(12):1484-94. doi: 10.1161/CIRCULATIONAHA.112.103051. Epub 2012 Aug 9.

20.

Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.

Diamond JM, Meyer NJ, Feng R, Rushefski M, Lederer DJ, Kawut SM, Lee JC, Cantu E, Shah RJ, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Weill D, Arcasoy S, Shah PD, Belperio JA, Wilkes D, Ware LB, Palmer SM, Christie JD; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2012 Sep 15;186(6):546-52. Epub 2012 Jul 19.

Items per page

Supplemental Content

Write to the Help Desk